Objective: To determine whether carotid endarterectomy under local anaesthesia is safer and as effective as under general anaesthesia. Design" Systematic review of the randomised and non-randomised studies. Materials, Studies were identified from the Cochrane Stroke Group's database plus additional handsearching and electronic searching. Methods: Two authors independently selected studies for inclusion and extracted details of trial quality and data on death, any stroke, myocardial infarction and other operative complications. Meta-analysis was performed using the Peto method. Results: There were 17 non-randomised studies (about 5970 patients) and only three randomised studies (143 patients), The non-randomised studies suggested that the use of local anaesthesia may be associated with clinically important reductions (approximately 50%) in the odds of stroke, stroke or death, myocardial infarction and pulmonary complications during the perioperative period, and with reductions in hospital stay. There were far too little data from the randomised trials to confirm or refute these findings: only one death and seven strokes were reported. Conclusions Non-randomised studies suggest potentially important benefits from performing carotid endarterectomy under local anaesthesia. However, these studies were seriously flawed and can only be hypothesis generating. The results must be confirmed in large well-designed randomised trials before any recommendations on the use of local anaesthetic can be made.
Introduction
Carotid endarterectomy significantly reduces the risk of stroke in patients with recent symptomatic, severe (>70%) internal carotid artery stenosis. 1' 2 However, the risk of stroke and/or death as a consequence of the operation was about 5%. 3 If this risk of perioperative stroke could be reduced, the benefits from carotid endarterectomy would be greater.
Performing the operation in awake patients under local anaesthesia (LA) has the advantage of accurate clinical assessment of the patient during surgery and the early postoperative period. 4 Any neurological deterioration during surgery can, therefore, be detected early and perhaps allow more appropriate use of selective shunting. In addition, the cardiac and pulmonary morbidity of general anaesthesia (GA) is * Please address all correspondence to: Prof. Charles P. Warlow, Neurosciences Trials Unit, Department of Clinical Neurosciences, Western General Hospital, Crewe Road, Edinburgh EH4 2XU, U.K. avoided 5' 6 and there is also a suggestion that operation under LA is associated with an overall shorter hospital stay, and so economic savings. 7 However, carotid endarterectomy under LA could have disadvantages. The operation may be more hurried and technically more difficult which may increase the risk of a poor result from surgery. Patients may also suffer undue stress and pain during the operation resulting in an increased risk of myocardial ischaemia. Finally, some surgeons find performing the operation under LA extremely stressful. There may also be certain advantages to operating under GA. For example, some general anaesthetics improve cerebral circulation, decrease the brain's oxygen requirement, and protect neurones against ischaemic damage. 8-1° But, at present, most surgeons (in the U.K. at least) favour GA; only two out of 326 vascular surgeons reported that they "sometimes" used LA in a recent survey. 11 The only way to reliably assess the relative risks and benefits of operation under LA vs. GA is by direct comparison in randomised controlled trials (RCTs).
We therefore undertook to review all such trials. However, in the absence of definitive data from these RCTs, we also reviewed the non-random comparisons to see if LA was sufficiently promising to merit a large scale RCT.
Material and Methods

Inclusion criteria
We sought to identify all the truly randomised and quasi-randomised (e.g. alternate allocation) trials and non-randomised studies that have compared LA with GA for carotid endarterectomy and which reported clinically relevant outcomes. Randomised and nonrandomised studies were, however, analysed separately as non-randomised comparisons almost always overestimate treatment effects. 12-~4 Trials which included any type of patient undergoing unilateral or bilateral carotid endarterectomy were considered eligible, regardless of whether the initial indication was symptomatic or asymptomatic carotid disease. more detailed searching of MEDLINE from 1966-1995 using the free-text term "carotid endarterectomy', of EMBASE from 1980-1995 using the terms "carotid endarterectomy" and "carotid surgery", and of the International Scientific and Technical Proceedings database of conference proceedings from 1980-1995 using the term "carotid endarterectomy".
Data extraction
Two authors (CT, CC) independently selected which studies met the inclusion criteria. There were no disagreements. For the randomised trials, details of the method of randomisation, the blinding of outcome assessments, losses to follow-up, cross-overs and exclusions after randomisation were extracted from the publications. For non-randomised trials, the method of allocation to GA or LA was recorded along with whether the series was prospective or retrospective, and whether consecutive or selected patients were included. For all studies, patient characteristics (age, sex, vascular risk factors, indication for surgery, etc.) and details of the operation (type of cerebral monitoring, use of carotid patching, use of shunts, use of perioperative antiplatelet therapy, etc.) were compared between the treatment groups. The outcome events were then extracted independently by two authors (CT, CC) using a standardised form, and cross checked. Discrepancies were resolved by discussion.
Some studies included patients who had bilateral operations but only recorded the number of arteries, not patients, in each group. The rates of death, any stroke, and myocardial infarction must obviously be reported per patient and not per artery. Therefore, if the number of patients was not available, we estimated it by multiplying the total number of patients by the percentage of arteries in each group. The rate of arterial complications and shunting was recorded per artery.
Proportional risk reductions were calculated based on a weighted estimate of the odds ratio using the Peto method. 17 This may be inaccurate in studies with large treatment effects and major imbalances in the number of patients in each group, is We therefore also calculated Mantel-Haenszel summary odds ratios using the EpiInfo statistical package (version 5). Since most of the outcome events assessed were rare, the odds ratios quoted will be similar to the relative risk ratios. Absolute risk reductions were calculated from the crude risks of each outcome in all trials combinedJ Heterogeneity between study results was tested using the standard Chi-squared test.
Results
There were 17 non-randomised studies 5-7' 19-31 including about 5970 patients (the exact number is unknown since some reports only gave the number of procedures) and three RCTs 32-34 (including just 143 patients). All were in English except one RCT 33 which was translated from French and one non-randomised study 22 which was translated from Italian. No studies were excluded and no ongoing trials have been identified (Table 1) 
Methodological quality of included studies
Randomised studies. The reporting of methodological quality was generally poor. Contact with the author showed that one triaP 4 did use a good method of randomisation (sequentially numbered, opaque, sealed envelopes) that adequately concealed allocation from doctors entering patients into the trial and so prevented selection bias. 35 In the other two trials the method of concealment of allocation was unknown despite correspondence with the authors. In all three trials, the blinding of outcome assessment was unclear.
In one study, 34 eight patients who were randomised to have their operation under LA actually had it done under GA. These patients were excluded from the analysis in the trial report although it appeared that none of them had any complication of surgery. For the purposes of this review, they have been included in the analysis in the LA group and we have assumed that none of them had an outcome event (i.e. we did an intention-to-treat analysis). In one trial, 11 patients (11% of all patients in the trial) underwent staged bilateral endarterectomies and were randomised twice. 34 Some of these patients may have had one operation under GA and the other under LA. The results were only presented per operation and therefore we have had to include the data on all operations rather than on all patients in our analyses. This assumes that each operation was an independent event which is clearly untrue (for example, a second operation is dependent on survival from the first operation!). However, it is unlikely that any of the patients who had bilateral operations had a clinical outcome event (e.g. stroke, myocardial infarction) after both procedures (although this was not specifical!y stated in the trial report) and so we felt it reasonable to include the results of all operations.
None of the trials reported major differences in baseline prognostic factors (e.g. age, previous stroke or transient ischaemic attack, vascular risk factors) between the two groups of patients although in some only limited data were provided. None of the trials commented on the use of patching or perioperative antiplatelet therapy in the two groups.
Non-randomised studies. Two studies were only published as abstracts, 24' 31 whilst unpublished data were obtained from the European Carotid Surgery Trial. Most (14/17) studies were done after 1~80. Only two non-randomised studies were prospective (European Carotid Surgery Triallists Collaborative Group (unpublished data)). 7 Twelve out of 17 stated that they included consecutive patients. Patients were divided between GA and LA using a variety of methods including surgeon and patient preference (nine studies), the hospital of admission (one study), and year of the operation (three studies), whilst four studies did not report how patients were divided into the two groups. 19 ' 22' 24' 31 In nine studies, the number of patients, as opposed to the number of arteries, in each group was unclear.
Most studies (13/17) reported no significant differences between the local and general anaesthetic groups for major vascular risk factors, but the numbers of patients with asymptomatic carotid stenosis were similar in the two groups in only seven studies. Four studies had more asymptomatic patients in the LA group, 5' 2°' 22' 28 whilst only one study had more asymptomatic patients in the GA group. 23 All patients who underwent combined carotid endarterectomy and coronary artery bypass grafting (CABG) clearly required GA. These patients are at increased risk of serious complication following surgery 6' 2°' 28 and if they were included in the GA group this may have biased the results against GA. In three studies, 6' 2°' 28 it was clearly stated that patients with combined carotid endarterectomy and CABG were excluded. In one study, the results of patients having a combined procedure were given separately and these patients were omitted from this review. 3° In the remaining 13 studies, it was unclear whether combined procedures were included in the GA group. Seven studies reported the use of carotid artery patching and in one 19 patching was more frequently used in the LA group (44.8% vs. 14.3%). Only two studies (European Carotid Surgery Triallists Collaborative Group (unpublished data)), 23 reported the use of antithrombotic agents in the perioperative period, and both used these agents more frequently in the LA group (100% vs. 92% and 50% vs. 26% respectively).
Other characteristics of included studies
Randomised studies. Two studies 33'34 used a cervical block and the other study 32 used an epidural block to provide LA. All of them used standard medication in the GA group. Only one study s4 reported the criteria for shunting in the LA group (neurological symptoms after clamping) and in the GA group (carotid artery clamp pressure <25 mmHg in patients with a previous transient ischaemic attack, <50 mmHg in patients with vertebrobasilar insufficiency and always if patients had had a previous stroke). In all the trials, the period of follow-up was unclear and we assumed that it was to the time of hospital discharge.
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Non-randomised studies. Fourteen studies used a superficial or deep cervical block in the LA group. One study 5 also used epidural anaesthesia and in two studies (European Carotid Surgery Triallists Collaborative Group (unpublished data)), 25 the method was not reported. Twelve studies reported the indication for shunting. All of them used a shunt if there were neurological symptoms during test clamping in the LA group. In the GA group, there were many different indications for shunting such as EEG changes (four studies), stump pressure <50 mmHg (two studies), <40 mmHg (two studies), <25 mmHg (one study), severe contralateral stenosis (five studies), recent ipsilateral stroke (2 studies), routine in all patients (two studies) and based on the "surgeon's choice" (one study). One study followed up the patients for more than 30 days (up to 2 years), 2° four followed up patients until 30 days (European Carotid Surgery Triallists Collaborative Group (unpublished data)), s' 6' 21 nine followed up patients until hospital discharge 7 ' 19' 22' 23' 25-27' 3°' 31 and one study only followedup patients for 24 h post-surgery. 29 In two studies, the duration of follow-up was unclear but was probably until hospital discharge or earlier. 24 ' 28 In many of the randomised and non-randomised studies important outcomes were not assessed. It was usually not possible to determine whether any strokes were ipsilateral to the operated artery or not (although most strokes will have been ipsilateral and in many studies we suspect that only ipsilateral strokes were reported). Often, neither the cause of death was reported, nor the severity of any stroke in terms of the resulting disability. Patient and surgeon satisfaction were not formally assessed.
Outcome
Randomised studies (Fig. 1 ). There were far too few outcome events to determine whether there were important differences between LA and GA in the risks of death, any stroke, or myocardial infarction. Local anaesthesia was associated with a marginally significant reduction in the odds of local haemorrhage (odds ratio [OR] 0.22, 95% confidence interval [CI] 0.05-0.99) and, as expected, a significant decrease in the number of shunts inserted (OR 0.16, CI 0.07-0.37). However, the latter two results were based on extremely limited data from a single trial and may, therefore, not be reliable. No trial reported pulmonary complications, cranial nerve palsies, or the duration of intensive care unit and hospital stay.
All trials recorded the blood pressure during and after the operation. However, the numbers of patients with significant hypotension or hypertension during and after the operation were not always given, and the definitions of hyper-and hypotension varied between trials. It was not, therefore, possible to perform a formal meta-analysis, and so we simply assessed the results qualitatively. In all trials the blood pressure dropped in the GA group after the induction of anaesthesia, and in one triaP 4 more patients in the GA group had significant hypotension during or after the operation than in the LA group (25% vs. 7%). This was not confirmed in another trial. 32 However, all trials showed that blood pressure tended to increase during clamping of the carotid artery in the LA group, and in two there were significantly more patients with significant hypertension in the LA group during surgery (Forssell 0% vs. 36%; Pluskwa 20% vs. 80%). Two studies suggested that hypotension was more common in the postoperative period in those who had a LA. 3233
Non-randomised studies (Fig. 2) . Local anaesthesia was associated with about 50% reductions in the relative odds of any stroke, and any stroke or death within 30 days of surgery. There were also significantly lower odds of myocardial infarction within 30 days of surgery in patients under LA. Only a few studies assessed local haemorrhage and cranial nerve palsies and so although there were no significant differences between the two groups for these outcomes, the confidence intervals were wide. Only five studies reported pulmonary complications. The definition of pulmonary complication varied between different studies and included pneumonia (four studies), pulmonary emboli (two studies), and prolonged intubation (one study). These complications were very rare but there were significantly fewer pulmonary complications in the LA group. Ten studies recorded blood pressure during and after the operation. Again, we were unable to assess the number of patients with hypertension or hypotension in each group. In general, hypertension seemed more common during surgery in the GA group, whilst hypotension postoperatively was more common in the LA group. As expected, many fewer shunts were inserted in those who had the operation under LA compared to GA (10.8% vs. 44.3%, OR 0.12, 95% CI 0.10-0.14). However, there was significant heterogeneity in the overall result (Chi-squared=156, df=11, p<0.001). There was also enormous variation in the use of shunting in the GA group and to a lesser extent in the LA group, depending on the selection criteria for shunt insertion in these patients. The percentage of arteries shunted in the GA group ranged from 3.3% to 100%, and in the LA group from 1% to 20%. If the studies were divided into those in which less than 50% and those in which 50% or more of operations in the GA group were performed with a shunt, the heterogeneity in results largely disappeared. LA was associated with 65% and 95% reductions in the odds (equivalent to 60% and 90% reductions in the relative risks) of shunting in trials in which the rates'of shunting in the GA group were less than 50% and more than 50%, respectively. Six studies gave some data about the total duration of hospital stay and two provided the duration spent in intensive care unit. Although formal meta-analysis could not be performed because the data were not normally distributed, the results suggested that patients having the operation under LA spent 1 day less in intensive care unit and 2 days less in hospital.
Discussion
A systematic review of the non-randomised studies suggested that there may be important clinical and Eur J Vasc Endovasc Surg Vol 13, May 1997 economic benefits in favour of performing carotid endarterectomy under LA, namely: a 40-50% reduction in the odds (and relative risks) for early stroke and early death; a 60% reduction in the odds for early myocardial infarction and pulmonary complications; and an apparent reduction in the length of hospital stay. There were no obvious increases in other operative complications with LA and, as expected, many fewer arterial shunts were required in those who had LA irrespective of the shunting policy used in patients having GA.
However, non-randomised studies are highly susceptible to bias, 12q4 in particular selection bias, i.e. the type of patients who had LA may have differed from those who had GA such that they were at lower risk of a poor outcome even before they had the procedure. Although the studies generally reported that the patients having LA and GA were compatible in terms of age, sex and vascular risk factors, this certainly does not imply that they were similar for all important prognostic factors. For example, there appeared to be more patients in the LA group who had an operation for asymptomatic carotid disease, suggesting that these patients may indeed have been at lower risk of poor outcome. 3 There may also have been differences in the ways that the patients in the LA and GA groups were treated which may have confounded the results. For example, there may have been differences in the percentage of patients in each group who received an arterial patch or who received perioperative antiplatelet therapy, both of which may be associated with improved outcomes. 17 '36 Few studies reported these data, but in at least two non-randomised studies there were major differences in the use of patching 19 and antiplatelet therapy 24 which favoured the LA group.
There were other biases in the non-randomised studies. Most of the studies were retrospective and included non-consecutive cases. It is therefore likely that some cases were missed or excluded, and this may have introduced bias. The person who assessed the outcomes in the patients would almost certainly have known whether the patient had received LA or GA and this may have biased their assessment of nonfatal outcomes (minor strokes, for example). These studies were also not analysed on an intention-to-treat basis, i.e. if the patient was planned to have the operation under LA but, in fact, had it under GA, they would probably have been analysed in the GA group. If the patients who crossed over differed in some systematic way from those who did not, then this may bias the results. Finally, publication bias may have seriously affected the results of the non-randomised studies; series showing poor outcome with LA may have been less likely to be submitted for publication. 37 There were also other methodological problems with the non-randomised studies. In particular, the duration of follow-up was short and was not constant across the different studies (it varied between hospital discharge and 30 days). Many of the studies did not report the number of patients (rather than arteries) in each group, most did not report whether the strokes were ipsilateral to the operated artery or whether they were disabling, and most made no assessment of patient (or surgeon) satisfaction with the procedure.
As a result of these biases, non-randomised studies can only be hypothesis generating and their conclusions must be adequately tested in well-designed RCTs. However, a systematic review of the RCTs showed that too few patients had been recruited and too few outcomes had occurred to confirm whether LA really offered significant advantages over GA. Once again, even in those trials that were performed, there were significant problems in quality: the method of concealment of allocation was inadequately reported and the duration of follow-up was again limited. Long-term follow-up may be advisable since operation under LA may be technically more difficult and therefore associated with worse long-term results. It was also unclear from the RCTs whether the outcome had been assessed blind to treatment allocation and at least one of the trials was not analysed on an intention-to-treat basis. Finally, as in the non-randomised studies, some important outcome measures such as patient satisfaction were not reported.
Implications for practice
Given that the overwhelming majority of carotid endarterectomies are presently performed under GA, much stronger evidence will be required from welldesigned randomised trials before LA can be recommended as the first choice for patients undergoing this operation. Such a recommendation would have major implications for the training of vascular surgeons. However, even if LA is shown to be safer than GA, it is unlikely that all operations could be performed under LA. In some patients the operation may be technically more difficult under LA, e.g. in those with short, fat necks. Some patients, perhaps 10%, 34 will also refuse to have the operation under LA ~ind some surgeons may refuse to perform the operation under LA.
Implications for research
The only reliable way to identify whether LA is the best option in most patients is to perform further welldesigned RCTs. The potential benefits are large. If the 50% reduction in the relative odds of perioperative stroke or death is confirmed, about 30 such events could be prevented per 1000 patients treated (assuming 6% perioperative risk of stroke or death). A trial of about 2000 patients would have a 90% chance of detecting such reduction with a 5% significance level. A trial of this size would obviously require collaboration amongst many surgeons and we are presently surveying surgeons who were involved in the European Carotid Surgery Trial to see if they would be interested in taking part in such a trial. However, even if a single definitive trial proves unfeasible, further small scale randomised trials could be performed which could then be added to the ongoing Cochrane review 38 to provide clearer evidence. Any such trials must randomise patients, not operations, using a method that ensures allocation is concealed from those entering the patients, and the outcome should be assessed blind to treatment allocation, preferably by neurologists. 39 The main outcome measure should be the risk of death or stroke (especially ipsilateral disabling stroke) within 30 days of the procedure but the risk of ipsilateral stroke during follow-up of several years should also be recorded. A measure of patient (and possibly surgeon) satisfaction would also have to be included as would the duration of intensive care and overall hospital stay to enable an economic analysis to be performed. If the costs of having the operation under LA were significantly lower than those of having GA, it would probably only be necessary to show that the use of LA was no worse than the use of GA and was acceptable to the patients. No further non-randomised comparisons should be published because these will add nothing to this dilemma, although surgical units do need to audit their results.
